When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer?
Callen
Jeffrey P
JP
D015897:Comorbidity; D019091:Critical Pathways; D003430:Cross-Sectional Studies; D003882:Dermatomyositis / Q000175:diagnosis* / Q000453:epidemiology; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis / Q000453:epidemiology*; D017285:Polymyositis / Q000175:diagnosis* / Q000453:epidemiology; D012307:Risk Factors